Investor's Business Daily on MSN

Insmed Screams To A 25-Year High, While IBD 50's Argenx Slides

Insmed stock surged early Thursday as Argenx stock rose more moderately. The top-notch biotech companies beat third-quarter ...
Investor's Business Daily on MSN

Why IBD 50's Guardant Health, Up 137% in 2025, Just Rocketed Again

Guardant Health stock rocketed again Thursday after the diagnostics company smashed Wall Street's third-quarter expectations.